Authors: Pinzani, P Orlando, C Raggi, CC Distante, V Valanzano, R Tricarico, C Maggi, M Serio, M Pazzagli, A

Citation: P. Pinzani et al., Type-2 somatostatin receptor mRNA levels in breast and colon cancer determined by a quantitative RT-PCR assay based on dual label fluorogenic probe and the TaqMan (TM) technology, REGUL PEPT, 99(2-3), 2001, pp. 79-86

Authors: Pazzagli, A Monti, MR

Citation: A. Pazzagli et Mr. Monti, Dysphoria and aloneness in borderline personality disorder, PSYCHOPATH, 33(4), 2000, pp. 220-226

Authors: Pallanti, S Quercioli, L Pazzagli, A

Citation: S. Pallanti et al., Effects of clozapine on awareness of illness and cognition in schizophrenia, PSYCHIAT R, 86(3), 1999, pp. 239-249

Authors: Pallanti, S Quercioli, L Rossi, A Pazzagli, A

Citation: S. Pallanti et al., The emergence of social phobia during clozapine treatment and its responseto fluoxetine augmentation, J CLIN PSY, 60(12), 1999, pp. 819-823

Authors: Pallanti, S Quercioli, L Pazzagli, A

Citation: S. Pallanti et al., Basic symptoms and P300 abnormalities in young schizophrenic patients, COMP PSYCHI, 40(5), 1999, pp. 363-371

Authors: Pallanti, S Quercioli, L Pazzagli, A Rossi, A Dell'Osso, L Pini, S Cassano, GB

Citation: S. Pallanti et al., Awareness of illness and subjective experience of cognitive complaints in patients with bipolar I and bipolar II disorder, AM J PSYCHI, 156(7), 1999, pp. 1094-1096